Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Preveceutical Medical Inc
C.PREV
Alternate Symbol(s):
PRVCF
PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based...
nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PREV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 06, 2023 7:01am
New Press Release - PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical is furthering the progress of its Sol-Gel Cannabinoid Therapies patent family based on...
read article.
(2)
•••
medmaryJ
X
View Profile
View Bullboard History
Comment by
medmaryJ
on Feb 24, 2023 1:42pm
RE:Bioasia 2023
Alot of insight on Twitter Tomorrow - speakers include Makarand Jawadekar and Max Narr
(2)
•••
medmaryJ
X
View Profile
View Bullboard History
Post by
medmaryJ
on Feb 24, 2023 1:35pm
Bioasia 2023
Google it. Lots of PreveCeutical members to represent Go PreveCeutical!!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 21, 2023 7:01am
New Press Release - Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - February 21, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces the appointment of Mr. Evan Ballantyne to the Company's board of directors (the "Board") effective February 17, 2023.Mr...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 07, 2023 12:10pm
New Press Release - IIROC Trade Resumption - PREV
VANCOUVER, BC, Feb. 7, 2023 /CNW/ - Trading resumes in:Company: PreveCeutical Medical Inc.CSE Symbol: PREVAll Issues: YesResumption (ET): 12:30 PMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 07, 2023 11:50am
New Press Release - PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on February 1, 2023, PreveCeutical has appointed ICON as the clinical research organization (CRO) to...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 07, 2023 10:59am
New Press Release - IIROC Trading Halt - PREV
VANCOUVER, BC, Feb. 7, 2023 /CNW/ - The following issues have been halted by IIROC:Company: PreveCeutical Medical Inc.CSE Symbol: PREV All Issues: YesReason: Pending NewsHalt Time (ET): 10:55 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 25, 2023 7:01am
New Press Release - PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
Vancouver, British Columbia--(Newsfile Corp. - January 25, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the grant of Australian patent no. 2018305726, titled "Disulfide bond containing compounds and uses...
read article.
(200)
•••
itwillgo1
X
View Profile
View Bullboard History
Comment by
itwillgo1
on Jan 23, 2023 3:23pm
RE:RE:RE:0.04$ and over 4.5M in volume!
If only there wasn't 600,000,000 shares out.
(0)
•••
limscon
X
View Profile
View Bullboard History
Comment by
limscon
on Jan 23, 2023 12:40pm
RE:RE:0.04$ and over 4.5M in volume!
it seemms the company is now in a much better situation: There is a new US patent for a product that is useful for fighting against diabetes and pain. In addition the SOL Gel program has a lot of
...more
(1)
•••
Brainboy16
X
View Profile
View Bullboard History
Comment by
Brainboy16
on Jan 10, 2023 2:34pm
RE:0.04$ and over 4.5M in volume!
PREV with an Comeback ? Would nice to see ATH at 0.15 soon again, after years for nothing but waiting. See you and good luck.
(24)
•••
bveilleu
X
View Profile
View Bullboard History
Post by
bveilleu
on Jan 10, 2023 2:17pm
0.04$ and over 4.5M in volume!
Looking good... GLTA
(24)
•••
bveilleu
X
View Profile
View Bullboard History
Post by
bveilleu
on Jan 10, 2023 2:16pm
PreveCeutical Signs Intercompany Sol-Gel License Agreement
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical")
...more
(200)
•••
itwillgo1
X
View Profile
View Bullboard History
Post by
itwillgo1
on Aug 24, 2022 8:24pm
Financials out
$2,638 in the bank. 500,000,000 shares out. Minimum 10-1 roll coming. 3 years ago when I saw the aquarium in their office at a grand a month I should have walked away. But Stevie
...more
(24)
•••
bveilleu
X
View Profile
View Bullboard History
Post by
bveilleu
on Jul 22, 2022 9:46pm
PreveCeutical Enters into Credit Facility Agreement
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle